Strategic Acreage Focused activity in New Jersey, New York, and Connecticut with experience in office, R&D, education, retail, industrial and residential sectors signals cross-sell opportunities across mixed-use and adaptive reuse projects within the tri-state area.

Financing Capability Recent financing activity including a $53.9 million fixed-rate deal for The Nell demonstrates strong capital access and debt-funding leverage, suggesting Prism could be a compelling partner for lenders or for developers seeking debt facilities or joint financing for upcoming redevelopments.

Leadership Growth Promotion of Anne Castiglia to Chief Financial Officer and a long tenure in finance indicate a stable, growth-oriented financial team, ideal for engaging in high-value, timeline-driven investment conversations and presenting scalable capital strategies.

Awarded Expertise Multiple honors for adaptive reuse and repurposing of excess corporate facilities and industrial buildings position Prism as a preferred partner for clients seeking transformative redevelopment, rendering collaboration opportunities with corporate divestitures and land-use conversions.

Biotech & Campus Potential Past acquisitions involving large campuses and plans to develop biotech-adjacent spaces (e.g., Roche campus) point to potential partnerships in life sciences real estate, lab spaces, and related research-tenant ecosystems, opening doors to biotech tenants and related developers.